MEmbranous Nephropathy Trial Of Rituximab

NCT01180036 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

130

Enrollment

OTHER

Sponsor class

Conditions

Idiopathic Membranous Nephropathy

Interventions

DRUG: Rituximab
DRUG: Cyclosporine

Sponsor

Mayo Clinic

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]